Think Neuro

31. Helping Patients and Advancing Science With a Psilocybin Trial | Karina Sergi, MS, MFT

Episode Summary

Karina Sergi is a licensed therapist, trained the old-fashioned way, but she is exploring a new tool that has been proven to help people who are struggling with persistent depression, addiction, and post-traumatic stress disorder: magic mushrooms.

Episode Notes

Karina Sergi is a licensed therapist, trained the old-fashioned way, but she is exploring a new tool that has been proven to help people who are struggling with persistent depression, addiction, and post-traumatic stress disorder: magic mushrooms. PNI is studying psilocybin, the active ingredient in mushrooms, as a treatment for alcohol use disorder, and Karina is a facilitator for the trial. She meets with patients before their psilocybin journeys, sits with them during the experience, then meets with them afterward to integrate the event into their daily lives. PNI founder Dr. Dan Kelly has said that psilocybin might be the most important compound for brain health that’s currently under study, and Karina agrees. She points out that magic mushrooms have been used by indigenous populations in Mexico for centuries, and she feels fortunate that the modern world has rediscovered them. Listen to this podcast to learn what a classically-trained therapist thinks about what has become a cutting-edge compound.